ecrin-mdr-crcClinical2023IPD Sharing (as of January 2023): UndecidedPeritoneal NeoplasmsCarcinomaColorectal cancerColorectal NeoplasmsColorectal Cancer MetastaticPeritoneal CarcinomatosisPeritoneal NeoplasmsCarcinomaColorectal CancerColorectal NeoplasmsColorectal Cancer MetastaticPeritoneal CarcinomatosisInterventionalhttps://newmdr.ecrin.org/Study/6231Netherlands4Peritonitis carcinomatosaCapecitabineMetastatic colorectal cancerECRIN MDRNot yet recruitingfalseGalunisertib Combined With Capecitabine in Advanced CRC With PMThis is a two-center open-label non-randomized proof of principle study consisting of a dose-finding part (phase I) and phase II study with Simon two-stage design investigating the anti-tumor activity of the combination of capecitabine and galunisertib in patients with colorectal cancer with peritoneal metastases.2023-04-156231NCT05700656